Reebok oxygen claim not scientifically proven

By Admin
The Advertising Standards Agency (ASA) has ordered sportswear firm Reebok to remove an advert which it says published unsupported claims. Reebok said i...

The Advertising Standards Agency (ASA) has ordered sportswear firm Reebok to remove an advert which it says published unsupported claims.

Reebok said in a promotional leaflet that its ZigTechApparel which is “engineered with Celliant fibres” is able to increase oxygen levels in the body by up to seven percent.

The company says that this is made possible because the fibres allow infrared light that is emitted from the body to be reflected back towards it, which in turn enables capillaries to relax and increases blood flow.  

However, the ASA feels that the studies which Reebok submitted to support the claim do not offer “documentary evidence for claims capable of objective substantiation.”

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

The leaflet featured F1 racing driver Lewis Hamilton who has previously been involved in advertising campaigns for Reebok, recently promoting the Reezig ZigTech trainers.

Hamilton appeared in the advertising leaflet wearing the Reezig ZigTech trainers, something which Reebok also received a warning for after the ASA said it could lead consumers to believe that the trainers have been engineered with the new technology, which they have not.

A spokesperson for Reebok said in a statement: “We accept but disagree with this ruling, which was based on one complaint about one leaflet.”

“The leaflet clearly showed the shoe on one side and the clothing on the other and, in our view, was not misleading.”

She went on to say that the Celliant fibres were a “clinically proven technology to which we remain firmly committed.”

 

Lewis Hamilton in a Reebok ZigTech advert:

Share
Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma